Caxton Corp Xeris Biopharma Holdings, Inc. Put Options Transaction History
Caxton Corp
- $16.2 Million
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding XERS
# of Institutions
143Shares Held
57.3MCall Options Held
87.6KPut Options Held
80.4K-
Black Rock Inc. New York, NY9.96MShares$21 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.61MShares$16 Million0.0% of portfolio
-
Bio Impact Capital LLC Cambridge, MA4.17MShares$8.79 Million1.51% of portfolio
-
State Street Corp Boston, MA3.22MShares$6.78 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.05MShares$6.43 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $287M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...